- Home
- KIDS vs LAB Comparison
KIDS vs LAB Comparison
Compare KIDS & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- LAB
- Stock Information
- Founded
- KIDS 2007
- LAB 1999
- Country
- KIDS United States
- LAB United States
- Employees
- KIDS N/A
- LAB N/A
- Industry
- KIDS Medical/Dental Instruments
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- KIDS Health Care
- LAB Industrials
- Exchange
- KIDS Nasdaq
- LAB Nasdaq
- Market Cap
- KIDS 629.1M
- LAB 562.1M
- IPO Year
- KIDS 2017
- LAB 2011
- Fundamental
- Price
- KIDS $27.16
- LAB $1.77
- Analyst Decision
- KIDS Buy
- LAB Strong Buy
- Analyst Count
- KIDS 7
- LAB 2
- Target Price
- KIDS $36.71
- LAB $2.88
- AVG Volume (30 Days)
- KIDS 319.1K
- LAB 1.7M
- Earning Date
- KIDS 03-05-2025
- LAB 02-26-2025
- Dividend Yield
- KIDS N/A
- LAB N/A
- EPS Growth
- KIDS N/A
- LAB N/A
- EPS
- KIDS N/A
- LAB N/A
- Revenue
- KIDS $189,673,000.00
- LAB $155,902,000.00
- Revenue This Year
- KIDS $39.07
- LAB $62.60
- Revenue Next Year
- KIDS $18.33
- LAB $9.19
- P/E Ratio
- KIDS N/A
- LAB N/A
- Revenue Growth
- KIDS 33.47
- LAB 48.23
- 52 Week Low
- KIDS $21.02
- LAB $1.21
- 52 Week High
- KIDS $35.99
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- KIDS 67.30
- LAB 46.48
- Support Level
- KIDS $22.63
- LAB $1.67
- Resistance Level
- KIDS $25.06
- LAB $2.14
- Average True Range (ATR)
- KIDS 1.45
- LAB 0.15
- MACD
- KIDS 0.49
- LAB -0.00
- Stochastic Oscillator
- KIDS 98.73
- LAB 32.73
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.